Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-04-07

Clinical Trial Update: Platelet-Rich Plasma (PRP) Injection in Treatment of Interstitial Cystitis [Phase 1]

View source ↗

Summary

Phase 1 trial to assess safety and feasibility of Platelet-Rich Plasma injections for interstitial cystitis. The document does not report results or outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Platelet-rich plasma (PRP)

Snippet

Sponsor: Buddhist Tzu Chi General Hospital | Conditions: Interstitial Cystitis | Phase 1 | Status: UNKNOWN